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1. Introduction 
The cancer is experessed as a disorder of chaos which cause an impairment of biochemical 
pathways in living metabolisms. In particular, mulfunctioning of the controls of cells 
throught the human body is mostly observed breakdown in cancer. Actually, this is not 
single way to form cancer such that there are many chance to initiate cancer in the body. We 
know that most of our cells carry their own genetic materials which give them an 
opportunity to multiply once more. And this condition describes why the proliferation of 
uncontrolled cells in countless parts of the body is extremely important. In fact, a terrible 
cell turnover involving death and replacement of cell, consists everlastingly in many tissues 
in human body.The presantation, development, and outcome of the cancer are extremely 
different and complex from one patient to other. Moreover the cellular and molecular levels 
of the cancer show the similar heterogenity and uncertainty. During cancer process cells 
undergo serious metabolic changes which give rise to proliferate in an excessive and 
untimely way. Also these changes allow to cancer cells escape surveillance by immune 
system (Merlo et al., 2006). Mutations originate in the DNA sequences should initiate cancer 
(Herceg and Hainaut, 2007). A single base change results in a changing aminoacid to be 
integrated into a protein synthesized. This is enough to extremely change the three 
dimensional structure of that protein. Besides the activity of the protein will change 
dramatically. A large number of bases can be converted by other DNA differentiations. This 
will lead to synthesis of abnormal proteins. Significantly, these alterations can be monitored 
by sequencing the DNA of the cell and used to detect of cancer. 
2. Cancer biomarkers 
There is no standard definition for “biomarker” that is universally used. In 1999, the US 
National Institutes of Health/Food and Drug Administration Working Group drafted a 
definition of a biomarker as a characteristic that is objectively measured and evaluated as an 
indicator of normal biological processes, pathogenic processes or pharmacological response 
to a therapeutic intervention. Biomarkers could be found in body and they are quantifiable 
molecules such as proteins, metabolites, DNA, or RNA. The abnormal concentrations of 
such biomarkers are indicator for a pathological condition in body, such as cancer. A 
biomarker also could be a molecule occured as a specific response of the metabolism to the 
presence of cancer. Every type of cancer could be associated with gene modifications and 
alterations in protein function. These gene modifications and protein changes can be useful 
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indicators of any cancer types. Besides they could be used to idetify prognosis, progression 
and therapeutic response of the disease(Sriwastava, 2007). For development, evaluating, and 
validating biomarkers guding principles known as the five-phase approach has been 
established by the US National Cancer Institute’s Early Detection Network 
(http://www.cancer.gov/edrn). The guidelines are very important for the usage of 
biomarkers in clinical applications. The five phases mentioned above ensure the principles 
and study design foundations for validating biomarkers for clinical use in early diagnosis of 
cancer. Phase 1 is the discovery pahse. Phase 2 is the validation phase in  which the 
biomarkers are verified to determine their capacity for distinguishing between people with 
cancer and those without. In Phase 3, the capacity of a biomarker to detect preclinical 
disease is investigated. Phase 4 comprehends screening tests. And the last phase 5, focuses 
on the large-scale population experiments that appreciate the role of the biomarker for 
detection of cancer (Pepe et al., 2001).      
3. Transducers used for detection of cancer biomarkers 
Early diagnosis of cancer plays a major role for treatment(Yuan et al., 2001; Faraggi and 
Kramar, 2000; Zhang et al., 2007; Wu et al., 2007). The analytical techniques which are 
improved for detection of biomarkers are based on highly specific molecular recognition 
between antibody and antigen to form immunocomplex (Andrey et al..1998). In Addition 
these analytical methods are used for clinical researches(Itoh and Ichhara,2001; Trull 2001; 
Worwood, 2002) and biochemical analysis (Panteghini, 2000; Rossier et al., 2002; Sato et al., 
2003). Because of highly specific molecular recognition characteristics of antigen and 
antibody, immunosensors are based on the interaction between antigen and antibody which 
are widely used for quantitative detection of biomarkers(Liu and Ju, 2005; Huang et al., 
2010; Rusling et al., 2009; Tang et al., 2008a). Transducers are devices that are employed for 
preparation of immuosensors and transform the biomolecular recognition signals into 
electrical signals.   Transducers can be divided into three main groups due to their sensing 
signal type; electrochemical, optic, and piezoelectric (Tothill, Turner, 2003). Choosing the 
exact transducer depends on a biomarker which is investigated and a signal which is 
occurred by biomarker reaction. It is very important to choose the correct transducer in 
routine utilization, for this reason the measurement principle of transducers are supposed to 
be proper for fabrication and commercial usage.  Recently necessity of this kind of practical 
and economic devices by the public makes biosensors more important and attractive.  
Therefore the utilizing of biosensors for development of clinical researches and self-using by 
patients increase all over the world. 
In this section; it is discussed that biosensor systems which are developed for the detection 
of biomarkers. The discussion will be focuses on the types of transducers used in the 
biosensor systems. First; brief information about cancer biomarkers which are diagnosed by 
the biosensor developed will be given, and after that the biosensor systems, that are 
developed for the detection any cancer marker, are discussed deeply. 
3.1 Electrochemical transducers 
Electrochemical biosensors are used in point-of-care devices since they were portable, 
simple, easy to use, cost effective and in most cases disposable. The electrochemical 
instruments used with the biosensors have been miniaturised to small pocket size devices 
which make them applicable for home use or the doctor’s surgery (Tothill, 2009). As a result 
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of antigen antibody interaction forms electroanalytical signals. Immunosensors based on 
measurement of these signals are widely used for clinical applications(Liu et al., 2001; 
S´anchez and Garc´ıa, 1999; Dai et al., 2003; Andrey et al., 1998). Electrochemical transducers 
divided into four groups due to their sensing signal type; amperometric, potansiometric, 
conductometric and impedimetric.(Liu et al., 2001; Zhang et al., 2004; Hianik et al., 1999; 
Ruan et al., 2002). However sensing the signals, which are formed by bioaffinity 
interactions, is possible to detect in narrow electrochemical techniques. Below of this 
passage, electrochemical biosensors those are developed for cancer biomerkers as now, are 
discussed. 
3.1.1 Electrochemical immunosensors developed for detection of Alfa-Fetoprotein 
Alfa-fetoprotein(AFP) is a normal serum protein that is synthesized by liver, yolk sac and 
gastrointestinal tract. AFP, a glycoprotein, is about 70 kDa weight and AFP contains an 
asparagines coupling residue. This biomarker levels are about 3mg/mL when pregnancy 
occurs then decreases dramatically after birth and reaches 10ng/mL. When overexpression 
occurs by AFP synthesizing tissues that indicates liver cancer. In addition to this situation 
points out an evidence of the risk of gamet cell cancer %75-80 positively(Bisceglie et al., 
2005; Yuen and Lai, 2005; Zinkin et al. 2008). Consequently the detection of AFP levels in 
lower levels is very important.  
J.-H. Maeng et al. developed a novel microfluidic immunosensor system which measured 
AFP levels. In this system, a PDMS-glass microbiochip was used, this microbiochip can 
detect AFP antigen antibody interactions by using electrical signals. There were platinum 
electrodes to gain electrical signals, a microchannel and pillar-type microfilter to blockade 
sample flow. These microbeads, microfilters and immune-gold silver coated 
complexes(IGSS) were used to amplify the response signal(Baschong and Stierhof, 1998; 
Lackie, 1996; Weipoltshammer et al., 2000); thus more sensitive signals obtain. For the 
detection AFP levels; microbeads were conjugated with streptavidine, antibodies were 
conjugated with biotins. AFP was added on these conjugates and AuNPs were conjugated 
with these conjugates on microchannels. After these experiment steps, secondary antibody 
was added on these conjugates. Eventually a silver enchancer solution was flowed to the 
system to amplify electrical signal. A microfilter was deployed on this PDMS-glass hybrid 
immunoassay microchip adjacent to platinum electrode. Therefore; firstly streptavidin-
biotin-AFP-Ab2 conjugates injected into the PDMS-glass hybrid microchip, secondly this 
conjugate move to the filters, the filters hold the conjugate solution and a bulk of conjugates 
formed on the Platinum electrode. Consequently, not only grater mass of bulk obtains and 
amplify signal, but also silver enchancer coated more conjugates and increased the 
conductivity and sensitivity. In addition simple to modify, high reaction efficiency and both 
molecular and cellular level analysis potantials make this immunosensor individual AFP 
sensing system(Bienvenue et al., 2006; Choi et al., 2002; Lim and Zhang, 2007; Sato et al., 
2002). A schematic representation of the biosensor is given in figure 1. 
The effect of incubation time and flow rate of conjugate solution are effective parameters for 
working of this immunosensor. The important points; minimum incubation time and 
antigen binding time are individual parts of this system. Nanoparticles, which are used for 
coating, have a nucleation sites that catalyze silver ion reduction(Liang et al., 2004; Su et al., 
2001; Xue et al., 2002), therefore this effect of reduction leads to elevated background signal 
which hides results and microbeads are coated silver enchancer to ignore self-nucleation. 
Because of using silver enchancer decreases the system’s conductivity between 1-10 kΩ 
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Fig. 1. A schematic representation of AFP sensing by a microfluidic immunosensor system 
furthermore doesn’t allow to form non-spesific binding, hence the system doesn’t need any 
pretreatment for measurement. Preparation of the immunosensor, incubation time and 
measurement time totally took less than 1 hour. Minimum detection limit of AFP is 1-103 
ng/mL and the correlation coefficient is 0.9746. 
Wei et al. aimed to develop a label free detection of an immunsensor. Graphene and thionin 
nanocomposit film were employed on immunosensor. Recently graphene sheets that consist 
of single carbon atoms in hexagonal shape, are single layer phenomenon(Kauffmann, 2007). 
Graphene sheets show stability and resistant to higher electrical potentials, due to these 
properties they are in use for biosensor technologies(Wu et al.,2010; Lin et al., 2009; Liu et al. 
2010; Shan et al. 2010; Wang et al. 2009; Babya et al. 2010). Because of nanomaterials’s high 
surface/volume ratio, nanomaterials provide high molecular loading surface. Furthermore 
these properties amplify electroactivity of thionin. This composition which is located on 
biosensor increases sensitivity. Graphene sheets were prepared according to Hummer 
method(Liu et al. 2008) graphene oxide was reduced a method improved by Y. Wang et al. 
(Y. Wang et al. 2009). Antibodies were immobilized on graphene sheets by a cross-linker 
agent glutaraldehyde. For prevention of non-spesific boundings, BSA was used to block the 
reactive aldehyde groups. AFP linear detection limit was between 0.05 and 2 ng/mL. The 
low detection limit was obtained 5.77 pg/mL(S/N=3). According to Wei et al. there were 
two factor that provided very low detection limit, firstly; because of high surface area of 
graphene adsorbed high number of TH and increased antibody conjugation, secondly; 
conjugation of GS-TH thin film layer increased electroactivity for detection low 
concentration limits. Three electrode system was used for this experiment. This 
immunosensor more sensitive than other systems which are employed nanomaterials(Su, 
2009 et al.; Sun et al., 2009; Wang, 2009 ). As it known that reproductivity is one of important 
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characteristics of an ideal biosensor. For the detection of 1ng/mL AFP, the relative standart 
deviation of measurements for five prepared electrode was 5.0% in which suggested 
precision and reproducibility of immunosensor was quite good. For the selectivity tests IgG, 
Vit. C, glucose and BSA were used and electrode respond was less than 5%, consequently 
selectivity of this biosensor was quite good. The stability test of this biosensor was stored 3 
weeks and the RSD result was 4.9%. The advantageous of the biosensor were simple to 
prepare, label free and practical measurement system. 
Tang et al. was developed another AFP detection immunosensor system which was based 
on conductometric and was employed carbon nanoparticles as label. The most important 
advantages of conductometric immunosensors are low prices, high sensitivity and low 
energy consumption in compliance with the micro system is perfect. Therefore; the novel 
biosensor designs often come from among the preferred methods(Hnaiein et al., 2008). 
Conductometric enzyme immunoassay principle of measurement systems, based on 
conductometric changing that results from a reaction occurs between two electrodes(Watson 
et al. 1987). According to the measurement system, most of antigen-antibody interactions are 
not able to occur any electrochemical signal. Thus the characteristics of electrochemical 
signaling enzymes (HRP, ALP, etc.) used for labeling the production of the signal obtaining 
to increase the low signal. In this manner; the technique could be used for development of 
many different measurement techniques. However some antibodies are limited to carry an 
enzyme. To solve this problem nanomaterials are combined with bioanalytical systems 
which decrease these limitations(Hiep et al,, 2010; MinhHiep et al.,2010; Yoo et al.,2010 ). 
Because of carbon nanoparticles used in this study (CNPS), the remarkable properties of 
amorphous sp2-π electrons is quite noteworthy(Dumitrescu et al., 2009). In this study, CNP-
HRP-anti-AFP, sandwiches were prepared on the basis of the method and conductometric 
determination of AFP was carried out as measurement system. Developed by the physical 
properties of nanoparticles used in this method can connect a maximum level of 
biomolecules with a created micro environment. Measurement of HRP to determine the 
concentration of iodine from the environment as a result of conversion is based on peroxide. 
According to electrochemical measurements carried out in a rapid increase in the reduction 
and oxidation current was observed that a sharp decline. According to Tang et al. the CNP-
HRP-anti-AFP conductometric signal is higher than the building of the reasons for 
conjugation; CNPS high surface area / volume ratio due to the creation of further 
conjugation with HRP, HRP-anti-AFP according to this ratio is less than just a result of the 
addition of AFP (not clear what is required), as has been reported. This optimization stages 
of the conductometric response of the system was prepared by increasing the 
electrodeposition time decreased. Linear range of the method is 0.1 to 500 ng / mL, as 
determined and Immunosensors 50 pg / mL, has a lower limit of determination. A 
summarize for AFP detection is given in Table 1 below. 
3.1.2 Electrochemical Immunosensors developed for detection of Annexin-II 
Lung cancer is a disease which is one of the worst ended cancer types. The symptoms of 
lung cancer and CT X-ray scattering of the disease with only four of process can be 
observed. The first stage of biomarker identification for diagnosis of lung cancer in recent 
years, based on the methods researched and began to develop rapidly (Heighway et al., 
2002, Hirsch et al., 2001 and Qiao et al., 1997; Singhalet al., 2005; Belinsky, 2004). Annexin II, 
also known as Annexin encoded by the gene ANXA2 used in the diagnosis of lung 
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Table Of Electrochemical Transducers For Detection of AFP 
Measurement 
Technique 
Immobilization 
Technique 
Low Detection 
Limit 
Lineer 
Detection Limit
Reference 
Conductometric
Microfluidic 
immunosensor 
system 
1ng/mL 1 to 103 ng/mL
Maeng et al., 
2008 
Amperometric 
Graphene and 
thionin nanocomposit 
film 
5.77pg/mL 0.05 to 2 ng/mL
Wei et al., 
2010 
Conductometric
CNP-HRP-anti-AFP, 
sandwiches 
50 pg / mL 
0.1 to 500 
ng/mL 
Tang et al., 
2011 
Table 1. Electochemical Immunosensors for AFP detection 
cancer(Takahashi et al., 1994). In terms of lung cancer, Annexin II what is a secreted protein, 
is not found in people with a solid, especially the stage of disease (Kim et al., 2007). In 
addition, the normal bronchial cells that secreted by intact lung bronchial epithelial cells can 
be used for the determination of the MUC5AC (Hovenverget al., 1996, Koo et al., 1999). 
Amperometric based electrochemical biosensors were developed for the early diagnosis of 
lung cancer biomarkers to determine the real-time mode (Wang et al., 1998; Darain et al., 
2005; Shiddiky et al., 2007a, b). Biosensors allow to determine specific molecules. For this 
reason, recently nanomaterials such as CNTs QDS AuNPs can be used to improve the 
performance of biosensors. Nanomaterials, high surface area / volume ratio, high 
electrocatalytic activity and can easily be modified in a manner compatible with 
biomolecules are very useful in terms of their use in biosensor technology (Shiddiky et al., 
2007a, b). Annexin II, as well as in electrochemical signal to give some of the biomarkers is 
not possible in theory, so biomarker is used for the determination of some special labeling. 
D.-M, Kim et al. developed an immunosensor system for the analysis of MUC5A and 
AnnexinII for early diagnosis of lung cancer. This system is based on amperometric 
measurement using a label as a AnnexinII biomerker. The system consists of glucose oxidase 
as a label(Shankaran and Shim, 2002; Shiddiky et al., 2007b) have been appointed as 
amperometric. Glucose oxidase(Shankaran and Shim, 2002; Shiddiky et al., 2007b) was 
employed instead of the enzyme HRP to reduction of the glucose and was immobilized on 
surface the hydrazine was used to provide stabilization(Rahman et al., 2005). 
Immunosensor’s measurement system is based on third-generation dendrimers 
immobilization with a covalent bond connection the foundation of hydrazine to polyclonal 
antibodies which are treated with AuNPs on the GCE (Rahman et al., 2005, Wang et al., 
2007; Katz and Willner, 2004). The use of amine dendrimers increases the sensitivity of the 
system two or three times(Shiddiky et al., 2007b). First, gold nanoparticles were 
electrodepozited on the GCE, and then polymerized with TTCA by electropolymerization. 
Carboxyl groups on the poly-TTCA were activated with NHS and EDC(Shiddinky et al.) 
with amine groups on the poly-TTCA method of forming the amine groups are activated 
with glutaraldehyde for further bindings. After these ends are bond to the activated 
hydrazine sulfate. After measurement, the system is ready for the immobilization of anti-
Annexin, Annexin II is required for the measurement of system pointing step of GOx, GOx 
solution of glutaraldehyde added to biomarker (Annexin II) activated on the connected 
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ends, after this steps the active sides to block the amino acids lysine (pH = 7 neutral) were 
used. The prepared immunosensor to verify the measurement controlled on biological fluids 
measurement should be made on the prepared normal bronchial cell cultures(Koo et al., 
1999). Anti-Annexin II / Hyd / AuNP / Den / Polt-TTCA / AuNP-modified electrode in a 
solution of glucose measurement was carried out depending on the interaction of Annexin-
GOx. The signal decreases the presence of free biomarker Annexin II, therefore, must be 
disposed of amperometric measurement of free as possible. This brought the measurement 
results have shown that 0.03 to 3 ng / mL Annexin II, the amount to be determined as linear. 
Dynamic range was measured in the 0.1 to 1 ng / mL. R.S.D. 2.2% (n = 5) and measuring the 
amount of the minimum 0.051 ng / ml, respectively. As we have seen extremely high 
sensitivity. Prepared bronchial cell cultures containing liquids examined of each species 
experiments of biomolecules to the response of immunosensor. Annexin II, a signal was not 
observed in normal cells, the addition of fluids with QCM measurements showed that the 
frequency change. The standard of the examination, with the added amount of Annexin II, 
280 ± 8 pg / mL was measured. As a result, D.-M, Kim et al. have developed a measurement 
system was extremely sensitive for early diagnosis of lung cancer. Sensitive measurement 
techniques such as QCM and impedance method with proven accuracy.  
3.1.3 Electrochemical immunosensors developed for the detection of CEA 
Carcinoembriyonic Antigen (CEA) is a biomarker occurring in cases of colon cancer, 
pancreatic cancer, uterine cancer and stomach cancer(Benchimol et al., 1989; Oikawa et al., 
1989, Goldenberg et al., 1976). CEA is an acidic glycoprotein is approximately 200 kDa 
molecular weight. Most of this glycoprotein synthesized during the formation of 
cancer(Benchimol et al., 1989; Schlageter et al., 1998). During the early diagnosis of cancer 
over-Express is vitally important. CEA is <2.5 ng / ml for a non-smoker man, while non-
smokers <5ng/mL are around. In the presence of cancer is higher than 5 times this 
amount(Duffy, 2001). 
W. Shi and Z. A reported a biosensor system based on electrostatic interaction for 
determination of CEA. The system shows good biocompatibility with immobilization 
materials have been chosen as, contains many amino group, a linear polysaccharide(Liu et 
al., 2010a, b) with negative charged groups on the chitosan(Liu et al., 2005) a good film layer 
observed due to form the nafion film. The main purpose of this system, a new membrane 
was prepared redox species is to adsorb on the film. Polietilendiamin were used to 
immobilization of antibody cross-linked on the electrode membrane and created with the 
electrolytic solution to facilitate the transfer of electrons between the AuNPs. Thus, antigen 
binding by blocking the electron transfer of redox-based measurement system's response 
was declined. (Liu and Gooding, 2009). AuNPs to be in 15 nm diameter(Yang et al. 2009) 
were prepared and were treated nafion to formed nafyon-AuNP complex. Ferrocene mixed 
with chitosan by sonication(Grabar et al. 1995). PEI treated with glutaraldehyde to modified 
electrode forming and the anti-CEA bound aldehyde ends. Nafyon-AuNP prevented 
leakage of ferrocene from system. With that of the secondary amine and negative charged 
Nafion and positively charged PEI to have facilitated the coexistence of two species via 
electrostatic interaction. A change in current density occurred after incubation with CEA. 
Stopping the transmission of electrical signals blocked electrostatic properties of 
electroactive layer of CEA. This was confirmed by a decrease in current. Prepared in 
conductivity compared to the control and AuNP-free sensor is determined to be less. In 
other words, the presence of AuNP increased the sensitivity of the system. Immunosensor 
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offers 0.01 to 150 ng / mL linear measurement. For the control of the prepared AuNP-free 
sensor showed a narrower range of measurement 0.03 to 100 ng / mL. RSD value of the 
sensor is 6%. Because of these properties prepared by different techniques, a measurement 
technique that has proved to be more effective than most Immunosensors (Wu et al., 2006, 
Pan and Yang, 2007; Mauritz and Moore, 2004; Limbut et al., 2006, Tan et al., 2006; Tang and 
Rhine, 2008, Tang et al., 2008, Zhang et al., 2008, He et al., 2008, Zhang et al., 2007, Liu et al., 
2010a, b, ; Thomson et al., 1969, Yang et al., 2010, Lin et al., 2004). 
X. Li et al. developed an immunosensor the poly-sulphanilic acid (PSAA) modified a glassy 
carbon electrode, due to the electrostatic interaction strategy. PSAA contains negative 
charge to interact the positively charged toluidine blue as a mediator and nano-Au as 
conductive agent facilitated binding of the anti-CEA in this system. HRP was used instead 
of BSA to prevent non-specific binding of the system. This is both non-specific bindings to 
blocked(Zhang et al., 2005; Zhuo et al., 2005, in press) and to use of TB as a mediator and 
H2O2 as a result of reduction feature makes the system more sensitive(Yang et al., 1998; 
Zhang et al., 2005). Radical cation method was used SAA to bond on GCE electrode(Cheng 
et al., 2001, Liu et al., 2000; Downard and Mohamed, 1999) to the PSAA / GCE modified 
electrode forming. Sulfonate groups of the modified electrode has been created with TB 
treatment. AuNP solution then immersed electrode to increase the surface area, this step 
was followed by immobilization with anti-CEA. Finally, the electrode immersed in HRP 
solution is ready for use as anti-CEA/HRP Immunosensors. All steps were followed by 
using the EIS. As is known, the electrode interface impedance spectroscopy is an effective 
method used in monitoring binding properties(Colvin et al., 1992, Gu et al., 2001). 
According to Fig 2 impedance spectroscopy a) bare GCE, b) the PSAA / GCE, c) the TB / 
PSAA / GCE, d) Au / TB / PSAA / GCE, and e) anti-CEA/Au/TB/PSAA/GCE modified 
electrode impedance shows the spectra. Electron transfer resistance showed a decrease, in 
the presence of Ferri/Ferro redox probe, TB and Au's. 
 
 
Fig. 2. Electrochemical impedance spectrums of glassy carbon electrode modified by poly-
sulphanilic acid (Li et al., 2005) 
It has been reported to the CV peaks increases in peroxide reduction when cyclic 
voltammetry studies of HRP in H2O2 solution. Incubation with CEA resulted in the 
reduction of CV peak current. The center of the electron transfer mediator in the formation 
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of Immunocomplex blocked impedance and CV studies has been proven again. In this 
system, the biosensor preparation strategy is based on electrostatic interactions, control of 
pH during preparation is considered to be very important. In addition, the pH of the 
enzyme can cause a change in the operation and characteristics of TB, the mediator. BSA 
and HRP As a blocking agent to prevent non-specific binding on prepared biosensors of two 
different proteins and their performances were compared. HRP was used the linear 
measurement range of the CEA were between 0.5 to 5ng/mL when BSA was used 0.8 to 5 
ng / mL. Lower determination limit of 0.2 ng / ml. X. Li et al. developed instead of BSA as 
blocking agent, the use of HRP, the system has become more sensitive. CEA determination 
of H2O2 in the environment didn’t show a differentiation of both blocking agent. Selectivity 
experiments in the studies with the AFP and hepatitis B, 2.38% and 3.24% RSD values, 
respectively. 20-day storage stability test of immunosensor, 20th day 97.5% initial activity 
remained at the end of the day persent.  
Z. Liu et al. developed an immunosensor system was modified nano-Au/PTC-NH2/PB 
biocompatible composite film and CEA were determined by the composite film forming. 
High chemical stability of the system, a well-known redox characteristics of Prussian Blue 
was chosen because it is advantageous in terms of low price, and magnetic properties(Xian 
et al., 2007). Some of the disadvantages of immobilization on the surface of the PB electrode 
is noticeable. Among these various techniques, electrode surface immobilized 
PB(Zakharchuk et al., 1995; Mario et al., 2003; Lupu et al., 2002, Yu et al., 2007) depending on 
the electrode surface leakage to the solution(Haghigi et al., 2004, Yuan et al. 2007). In this 
study, a new organic compound was synthesized to create a semiconductor film. With 
ethylene diamine 3,4,9,10-perilentetracarboxylicanhydrite selective and sensitive to the 
formation of a layer of PTC-NH2 formed. Because of the well-known electronic properties of 
PTCDA (Gustafsson et al., 2006; Forrest, 1997) investigated the advantages of the production 
of a new substance derived in this matter. PTC-NH2 in the gaps on the creation of the PB 
film of organic-inorganic moved to create a component that has led to the surface because of 
the abundance of the amino ends of the leakage is prevented. Another advantage brought 
on the AuNPs, adsorbed by aminogroups, high specific surface area and lead to 
amplification of the response of the sensor by creating a structure that is biocompatible. 
Nano-Au / PTC-NH2/PB/GCE electrode of the recent anti-CEA-treated with BSA to 
prevent nonspecific binding. Impedance and CV datas were used to investigate for electrode 
interface. Modification of the electron transfer to the PB resistence reduced with the PTC-
NH2 modification as a result of increased resistance. Modification with anti-CEA increased 
resistance so successfully. For electrochemical sensor prepared and covalent bond-free 
Immunosensors effecting parameter was pH. The temperature is also a defective factor that 
denatured biomolecules. Prepared immunosensor for CEA determination in linear range is 
between 0.05 to 2 ng / mL and the lower limit of determination is 0.018 ng/mL, R2 = 0.995. 
Selectivity experiments carried out with the hepatitis B antigen, CEA, AFP, ascorbic acid, L-
cysteine, L-lysine, L-glutamic acid and 1.4% BSA, CV experiments showed that this 
differentiation is also acceptable. 60-day storage stability of the prepared immunosensor 
observed and RSD value is 4.1%. Liu et al. developed by the PTC-NH2 compound produced 
in this system by increasing the stability of PB increased the accuracy of the method. 
Consequently lower limit of determination, and the fabrication steps produced quite simple. 
Song et al. developed an immunosensors system for the determination of CEA to interface 
the gold nanoparticles and Prussian Blue with the nanoparticle/nanocomposite multi-layer 
structure. Advantage of this system nanomaterials and composite forms based on made of 
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chitosan and the immobilization of gold nanoparticles and multiwalled carbon nanotube 
(MWCNT) interface was used. MWCNTs are widely used in recent years because of high 
chemical stability, good electronic properties and mechanical stabilities(Wang and 
Musameh, 2003). MWCNTs can not show dissolution most of the features in environments 
containing water, to facilitate the dissolution of chitosan(CS) utilized in this study(Lu et al., 
2005). In this way, the CS-MWCNT nanocomposite have shown very good agreement for 
potential applications(Liu et al., 2008, Spinks et al., 2006). In this way, the CS-MWCNT as a 
result of modification of amino groups on chitosan AuNP binding brought in a structure 
that allows for the convenience, the sensitivity of the system with a combination of both 
MWCNT and AuNPs were increased. Showing the redox activity of immune molecules are 
mostly used in the analysis of protein analysis, amperometric, redox activity of the PB in this 
study were chosen because of the well-known properties(Fiorito et al., 2005, Zhang et al., 
2007). MWCNTs were activated by acid solution and then mixed in an ultrasonic bath CS 
and AuNPs after this stage of the nanocomposites structure formed. Liu et al. Synthesized 
PBNPs according to the method developed by(Liu et al., 2002). In this study, using the CS-
MWCNTs-AuNPs-PBNPs as redox probe modified composite structure was immobilized on 
the AuNPs and nitrile groups by electrostatic interactions. CS-MWCNTs-AuNPs solution of 
suspension was spread on the GCE electrode after the modification of GCE-PBNPs was 
performed with the above principle. BSA used to block non-specific binding of anti-CEA 
solution was prepared by immersion and CV measurements confirmed that the 
immobilization of impedimetric as expected. Developed Immunosensors system of linear 
measurement range 0.3 to 120 ng / ml range, R2 = 0.9976, and the lower limit of determination 
0.1 ng / mL. The best results are given for sensitivity, specificity and reproducibility. Song et 
al. were developed an anti-CEA/AuNPs/PBNPs/CS-MWCNTs-AuNPs/GCE modified 
electrode system in this study. By increasing the surface area of nanocomposite structure with 
PBNPs of the amount of the substance and the immobilization increased sensitivity and 
leakage could be prevented and thus can be used for clinical studies. 
Y. Wang et al. Developed a Molecular imprinting-based potentiometric sensor system for 
the determination of cancer biomarker. Molecular imprinting process that artificial materials 
use of a very large area of the molecules determine to use(Pauling, 1940; Sellergren, 2001; 
Piletsky et al. 2001; Cram, 1988; Bartsch & Maeda, 1998; Mosbach, 1994; Sellergren & Shea, 
1994; Haupt, 2003; Vlatakis meat al., 1993; Wulff, 1995). Used on a layer of polymer molecule 
imprinting method according to pattern creates a cavity, cavity’s geometric pattern that is 
similar to the properties of the molecule carrying the groove to be connected. SAM is used 
as a surface molecular imprinting in this system. As the hydrophobic and hydrophilic 
groups of the SAM shown to interact with protein domains. Gold-coated silicon chip 
technique on a Au-S bond via alkenthiol molecules containing hydroxyl end is connected to 
water, this may very well organized in a single layer(Porter et al., 1987, Bain et al., 1989). If 
the target molecule to the surface during the binding of this molecule in the formation of 
monolayer taking place within the matrix of SAM forms imprinted. As a result of the 
removal of the mold layer also leaves behind a cavity. In terms of surface molecule template 
is compatible with the appropriate specificity by showing mold cavity is connected to the 
molecule performs and thus measured. The amount of potential to change the amount of 
binding molecule with the environment, as a result of decreasing the measured 
potentiometrically(Janata, 1975). Surface characterization studies performed by XPS and 
AFM. This study was carried out to determine CEA in colorectal cancer cell cultures. Linear 
determination is between 2.5 and 75ng/mL. Specificity studies of the electrode response 
www.intechopen.com
 
Biosensors for Cancer Biomarkers 509 
were observed in an experiment with bovine hemoglobin. While the normal human cell 
cultures in the system of measurement used in the CEA and CEA than the amount of excess. 
CEA concentration increase not only determines the speed, but also increases the potency 
increases differentiation. The sensor response time were obtained in 1 hour. If the protein is 
smaller than the thickness of the SAM molecule, the mold is only a small portion will be 
sufficient to interact(Porter et al., 1987, Boehm et al., 1996; Brayer et al., 1995). Both the 
hydrophobic and hydrophilic surface of CEA(Duffy, 2001;) and gold adsorption ability of 
proteins(Ostuni et al., 2001; Hook et al., 1998, Kaufman et al., 2007, Tang et al., 2004) with a 
molecular shot has to be strong. 
Vismanathan et al. Developed a MWCNT and liposome technique for the determination of 
CEA was prepared by using ferrocene to screenprinted electrode system developed with the 
use of single-use electrochemical Immunosensors. Recently, on the screen printed electrode-
based electrochemical immunosensors extremely useful, because of designed for single use 
and portable use(Valat et al., 2000, Wu et al., 2006, Gao et al., 2003). Nanomaterials, 
especially carbon nanotubes, have high strength, thermal and electrical properties because 
of the very useful, biosensor immobilization materials that increase the limits of sensitivity 
(Hansen et al., 2006, Pathak et al., 2001). Vismanathan et al. CEA levels in serum and saliva 
was arrested in his study polietilenimin Screen Printed MWCNT modified electrode and 
ferrocene carboxylic acid, encapsulated CEA were used in liposomes. Ferrocene labels used 
in preparation of liposomes were prepared by the method of reverse phase to blow (Ho and 
Hsu, 2003; Ho and Huang, 2005; Ho et al., 2007). Liposomes dipalmitoil 
phosphatidylcholine(DPPC) and phosphatidyl dipalmitoil glycerol (DPPG) have been 
prepared. Thiolat groups, where created on the liposomes, were incubated with CEA and 
unreacted thiol groups were blocked by the etilenmaleimid. Carboxylic acid, sulfuric acid 
and nitric acid oxidized MWCNT functionalize MWCNT was obtained(Tseng et al., 2007). 
PEI was modified with MWCNT suspension drops on the SPE. Modified electrode was 
immobilized covalently antibodies with glutaraldehyde. Non-specific binding ends of the 
unreacted aldehyde prevented by BSA. Liposomes were created to be characterized by 
determining the homogeneity of the lipid results were obtained from each liposome(eq 1). 
aL per lipid head group surface area, d is the hydrodynamic radius, t the thickness of the 
lipid bilayer (Singh et al., 1996). 
 Ntot=
గ௔௅ [݀2 + (d-2t)2] (1) 
Thus, the number of CEA on the liposome can be calculated theoretically. From these data, the 
lipid molecule is connected to the CEA, 2 or 3. As a molecule of about 3900 that correspond to 
molar 0.023. One was entrapped in a liposome, the liposome containing ferrocene 1x1013 to 0.2 
M was calculated for per milliliter. MWCNT on the negative ends of the positively charged 
PEI chains were interacted. Thus, measuring the limits of the modified electrode 5 pg / ml and 
500 ng / ml, respectively. Reproducibility of immunosensor to submit actual samples for 
accurate determinations shows promise in clinical trials is available 
Xiang et al. have developed a ultrasensitive CEA immunosensor stratified layer by layer to 
determine the multi-enzyme system. In this study with the creation of multi-enzyme layer 
on the SWCNT with an increase of the enzymatic reaction to enhance signal. LBL (layer-by-
layer) will be marking technique, allows to the amounts enzyme catalytic activity to an 
increase in the signal(Munge et al., 2005, Wang et al., 2006, Zhao and Ju, 2006). On the other 
hand the connection of multi-layer enzyme dramatically increases the analytical 
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signal(Limoges et al., 2008; Limoges et al., 2006, Bauer et al., 1996; Schelde et al., 2001 and 
Mak et al., 2003, Kwon et al., 2008). Primarily on the preparation of SWCNT multienzyme 
LBL layer was prepared by modification of immunosensor(Munge et al., 2005, Zhou and 
Zhang, 2009). Alkaline phosphatase was immobilized on SWCNT has been modified with 
PDDA. SWCNT-(PDDA / ALP), conjugation was repeated several times, and thus the same 
system SWCNT-(PDDA / ALP)4 bioconjugate the structure formed. This was adsorbed on 
PDDA conjugates negatively charged layer by repeating the same step again to add ALP 
binding immunosensors Ab2 was formed. GCE electrode surface was modified with 
immobilization o-ABA solution was prepared containing H2SO4(Preechaworapuna et al., 
2008). Reactive carboxylic Nb1 ends activated NHS, EDC after the modified electrode was 
treated to blocked by ethanolamine. After SWCNT-(PDDA-ALP)4-PDDA-PSS-AB2 
bioconjugates was immobilized on electrode surface. ALP‘s isoelectric point is above this 
point will be charged pozitively easily adsorbed by PDDA. Enzyme layers by increasing the 
limit of determination decreased to very low values of the signal also increased the use of 
coenzyme is as follows: 0.1 to 1000 pg / mL defined as linear, the lower limit of 
determination in the FMA has dropped to 0.2. Specificity studies of myoglobin and lyzozme 
are not experienced a significant increase immunosensor responce these experiments also 
showed that high selectivity. Immunosensor’s RSD value is 6.9% in the good results showed 
that the reproducibility and accuracy. As a result of prepared immunosensor for clinical 
trials because of it is quite susceptible to use the results. Table 2 summarizes the 
electrochemical immunosensors used for detection of CEA below. 
 
Table Of Electrochemical Transducers For Detection Of CEA 
Measurement 
Technique 
Immobilization Technique
Low 
Detection 
Limit 
Lineer 
Detection 
Limit 
Reference 
Amperometric 
anti-CEA/ PEI/Nafyon-
AuNP/Fec/ 
0.01ng/mL 
0.01 to 150 ng 
/ mL 
Shi and Ma, 
2011 
Voltammetric 
And 
Impedimetric 
anti-CEA /Au / TB / 
PSAA / GCE 
0.2 ng / mL 
0.5 to 
5ng/mL 
Li et al., 2006 
Voltammetric 
Anti-CEA-BSA/Nano-Au 
/ PTC-NH2/PB/GCE 
0.018 ng/mL
0.05 to 2 ng / 
mL 
Liu et al., 2008 
Voltammetric 
anti-
CEA/AuNPs/PBNPs/CS-
MWCNTs-AuNPs/GCE 
0.1 ng / mL 
0.3 to 120 
ng/mL 
Song et al., 
2010 
Potentiometric 
SAM-CEA/Au Electrode 
Molecular Imprinting 
2.5ng/mL 
2.5 to 
75ng/mL 
Wang et al., 
2010 
Amperometric 
MWCNT and ferrocene 
labeled liposome on SPE 
5 pg/mL 
5 pg/mL to 
500ng/mL 
Vismanathan 
et al., 2009 
Amperometric 
SWCNT-(PDDA / ALP)4-
Ab2 
0.1pg/mL 
0.1 to 1000 pg 
/mL 
Xiang et al., 
Table 2. Electrochemical Immunosensor for Detection of CEA 
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3.1.4 Electrochemical immunosensors developed for the detection of CRP And TNF 
C-reactive protein is a biomarker that is118kDa and is circulating in the blood, the 
biomarker synthesized by interlokin6, in the liver 
(http://www.scrippslabs.com/datatables/proteinabsorbance.html, 2007; Weinhold and 
Rüther, 1997). Plasma levels are lower than normal human, 3μg/mL (Hu et al., 2006; Verma 
and Yeh, 2003). Used to determine levels of CRP as a prognostic indicator of gastric cancer. 
M.-H. Lee et al. developed the source and drain electrodes placed on the surface potential 
measurement was carried out under a layer of semiconductor SiNW field-effect transistors 
in the system. Nanotechnology-based sensors through the mechanisms determining the 
limits and sensitivity have increased in recent years nested. Direct labeling of biomolecules 
and nano-structures provide an ultra-sensitive manner possible to determine. Foundations 
this type SiNW Fet transistor and connecting the surface of the positive or negative charge 
on the surface accumulation of a protein based on the principle of conductivity decrease or 
increase(Patolsky et al., 2006). This mechanism allows the realization of high sensitivity and 
real-time measurement. In this study, silicon nano-wires single-crystal substrates were 
prepared according to the method of thermal oxidation of p-type substrate, n type substrate 
and n-type substrate to face grain orientation(Lee et al., 2007). Gold colloids were prepared 
reduction of sodium citrate(Frens, 1973). Aldehyde-ended single-layer surface modification 
of SiNW surface is the principle of creation. In general, the use of oxygen plasma as a 
chemical reaction of the hydroxyl group is based on creating a glutaraldehyde 
solution(Patolsky et al., 2006). In this study, oxygen plasma cleaning to be surrounded by 
the surface amine performs a mapping of the surface silanol. Then aldehyde groups formed 
and paired with CRP bound to the antibody on the created surface. CRP and CRP antigen 
SiNW after reaction with gold nanoparticles formed to conjugate. This system is designed to 
work in a flow system, containing two PDMS micro-pump system, created a flow to input 
and output channels, microchannels 600 micrometers in length in the flow of the system by 
performing the analysis of the protein has led to measurement area. In this study, the actual 
serum samples from patients were used. Isoelectric point of CRP between 5 to 6, which is 
negatively charged in solution is neutral for this reason, flow to p-type SiNW Fet. Previous 
studies which Fet SiNW are used, to determine the lower limits of s have dropped to 1fmole. 
In addition, the observing effect of sodium chloride in the SiNW youth initiative. 13 CRP-
positive patients, the diagnosis of gastric cancer biomarkers combined CEA and CA19-9 can 
be determined. Measurements of serum donors SiNW Fet between 3.2 to 10.4 
micrograms/milliliter were measured. Despite the biomarkers measured in this system of 
measurements to be made so sensitive that low sensitivity of the system determines 
limitations. According to the results presented in this SiNW Fet signals proportional to the 
levels of CRP. Therefore, the diagnosis of gastric cancer, especially in the early stages, the 
determination provides a great asistance. 
Qureshi et al. was developed Immunosensors system by using unlabeled array capacitors 
combined with gold for the determination of multiple biomarkers will be integrated 
biosensor systems have evolved to the surface of silicon oxide. Capacitive immunoassays 
are phenomenon immunochemical tests in recent years, the development and manufacture 
of hand-held devices used for personal use. Affinity-based capacitive sensors that can 
respond to even very low levels the opportunity to direct analyte measurement techniques. 
Changes in dielectric properties of the measurement basis on or load distribution depend on 
the conductivity change in the exchange of antigen-antibody interaction on the surface of 
the electrode. Recently, the label was developed the redox mediator used in capacitive 
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biosensors in this system(Carrara et al., 2009; de Vasconcelos et al., 2009; Saravan et al., 
2008). In this study, the covalent bonding on an optimized GID is connected antibodies via 
epoxy-silanisation(Saravan et al. 2008), this method is less prone to sensitivity, the other less 
cheap silicon dioxide with a high-sensitive measurement applied to nanocrystalline 
diamonds(Quershi et al. , 2009). GID arrays of silicon oxide surface with a thick layer of 
tungsten, first a thin gold layer is coated in advance to allow for the creation of an easier 
way. According to this structure, the capacitor arrays includes 24 fingers GID(Quershi et al., 
2010). First, arrays were treated with MPA to SAM created layer free carboxyl groups was 
activated by NHS / EDC and antibody is ready for immobilization. Phase of antibody 
immobilization was created in two formats: the first method, each GID capacitor with a pure 
antibody, while the second method, equal amounts of multiple antibodies (CRP, TNF and 
IL-6) was co-immobilized. Dielectric parameters of different antigens were treated arrays 
were prepared. BSA was used as a non-specific protein for a negative control. Limits for the 
determination of biomarkers measured in linear; 25pg/mL to 25ng/mL. The complex 
dielectric constant is a result of the change in dipole momenttes of biomolecules which 
differences amino acid sequence of elements that can bring about change in the dipole 
momentte(Antosiewicz, 1995). To the determination of several biomarkers of cancer as it is 
known to determine the accuracy of diagnosis of cancer is increasing. Most of the other 
proteins secreted as a result of the cancer biomarker can be found in a unified manner. 
Quareshi et al. developed for multiple analyses by allowing the disease to other single-
analyte immunosensors advantageous and gives accurate results in this array technology. In 
addition, the silicon oxide background is fast, simple and sensitive measurements, allowing 
the hand-held personal devices allows the development of diagnostic devices. Table 3 
summarizes the electrochemical biosensors for analysis of CRP and TNF.  
 
Table Of Electrochemical Transducers For Detection Of CRP and TNF 
Measurement 
Technique 
Immobilization 
Technique 
Low Detection 
Limit 
Lineer 
Detection Limit
Reference 
Potentiometric Anti-CRP/SiNW Fet 3.2μg/mL 3.2 to 10.4 μg/mL Lee et al., 2010 
Capacitance 
Anti-CRP/MPA/Au 
Electrode 
25pg/mL 
25pg/mL to 
25ng/mL 
Qureshi et al., 
2010 
Table 3. Electochemical Immunosensor For Detection of CRP 
3.1.5 Electrochemical immunosensors developed for detection of PSA 
Prostate cancer is one of the most common cancers in men in most types of cancer among 
the three leading causes of death (Jemal et al., 2006). For this reason, the most important part 
of treatment of the disease is diagnosed early. Early detection of protein-based biomarkers 
for biosensor technology in the last few years as it is known to be very beneficial for the 
early diagnosis of determination. Prostate-specific antigen (PSA), to determine the most 
common tumor marker is used on prostate cancer(Benson et al., 1992, Bradford et al., 2006; 
Brawer, 1999, Stephan et al., 2006). PSA is a glycoprotein of 32-33 kDa single chain (Landis et 
al., 1999, Cesar et al., 2004;), a part of 93% sugar residue peptide also contains the rest of it is 
produced by the prostate tissues(Loeb and Cantolona, 2007 ). 
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Y.-Y. Lin et al. developed an immunochromatographic/electrochemical biosensor system 
which is nanoparticle-labeled for the determination of the PSA. This study obtains two 
steps; the first step rapid immunochromatographic assay with a combination of simple and 
sensitive immunoassay with a diagnosis after the device. As is well known a specific 
binding substance chromatography after moving from the principle of signal, depending on 
the diagnosis has been developed. Very fast measurement system offers the possibility of 
one or two minutes. In the first part of the design is based on the visual judgement, by using 
a dye or a gold nanoparticle provides a quick and qualitative determination (Jin et al., 2005; 
Nagatani et al., 2006, Zhang et al., 2006, Fernandez-Sanchez et al., 2005) . But not only is not 
sufficient for the qualitative determination of the correct results therefore reveal its high 
sensitivity due to the sensitivity of a combined electrochemical immunoassays permit 
designed to provide a more accurate result. Advantages brought by nanotechnology in 
recent years began to develop nanoparticle-based Immunosensors thus increase the signal 
trace of biomarkers to identify and obtain a more precise measurement is 
possible(Georganopoulou et al., 2005; Huhtinen et al., 2004; Jain, 2005, Liu et al., 2006, Liu 
and Lin, 2007, Liu et al., 2007, Nam et al., 2003, Wang et al., 2006). Y.-Y. Lin et al. developed 
to increase the signal in this system made of CdSe @ ZnS quantum dots (QDS) are used to 
mark the anti-PSA antibodies. Quantum dots can contain hundreds of very useful particles 
and biocompatible terms of marking, and signal enhancement. In order to take the 
measurement Y.-Y. Lin et al. anti-PSA-QD prepared (Wu et al., 2007; Wang et al., 2008). 
Then, immunochromatographic/electrochemical biosensor prepare, the system includes 
immunochromatographic strip and this strip is composed of three parts; sample loading 
area, the second part of the anti-PSA-QD loaded contact area, the third of the area consists of 
covalently bound anti-PSA to  Screen Printed electrodes were placed under the test area. 
Modifications by using diaminothiofen to form the membrane with the space arms. Thus, 
the modified nitrocellulose membranes were later activated by glutaraldehyde, then 
incubated with the anti-PSA solution. Horizontal flow in the system, BSA and Tween 
blocking dried using a membrane with N2 gas. Anti-PSA-QD conjugates were dried by 
applying the last part of the glass fiber. PSA application of this system was performed in 
various advantageous immunochromotographic primarily be facilitated removal of the 
extra buffer, other advantage, ten minutes of the measurement is performed. CdSe quantum 
dotls created the nucleus and shell contains ZnS. The sample is applied to the system as part 
of the walk by the PSA QD-labeled anti-PSA-QD complex consists of an complex. 
Membrane was adsorbed on the anti-PSA-QD bound to act on the membrane with anti-PSA 
to PSA, which itself depends on covalent, QD marked when the test section consists of a 
sandwich complex. Here, an appropriate reaction (1M HCl), QD complex is dissolved and 
the remaining free cadmium ions in the electrochemical measuring system to provide to be 
quantify. This system is ideally suited for making quantitative measurements and the signal 
gain is proportional to the amount of the PSA. PSA’s linear measuring range between 0.05 to 
4 ng / mL in this system and R2 = 0.995 was determined. RSD value of reproducibility was 
6.4% and the lower limit of determination of 0.02 ng / ml. This combined and developed 
system is cheap, fast and sensitive due to the use of devices developed for clinical 
applications, and paved the way for personal use. 
J.F. Rusling et al. developed electrochemical sensor technology by other nanomaterials have 
been used. As is well known properties of carbon nanotubes are extremely useful materials 
that show metallic or semiconductivity (Munge et al., 2005). SWCNTs were used in the 
sensor at the two stages; electrode surface with higher conductivity and higher surface area 
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to provide more adhesion to the surface with analyte signals to be more sensitive and are 
used to mark the second part, by moving a larger amount of enzyme, and secondary 
antibodies amperometric signal is used as to increase(Mung et al., 2005). In this study, the 
surface of the carbon nanotube electrode has been modified by creating forest. SWCNT on 
the surface to be more intense forest electrode coated with a thin film layer nafyon. The 
second stage used for the oxidation of carbon nanotubes formed by acid carboxyl ends of 
the enzyme, peroxidase, and secondary antibody was immobilized. According to this 
approach, the CNT in each 100nm enzyme are 170 HRPs (Jensen et al., 2008). This also 
provides a determination of ultra-low levels of PSA (4 pg / ml) (Yu et al., 2006). Limitations 
of the generated results were extremely sensitive for nantube forests. The fact that 
nanotubes together with separation is difficult and increasing heterogeneity among the 
problems to be tackled. Depending on these results, Rusling et al. nanoparticles modified 
electrodes have deposited layer by layer(Lvov, 2001). First a polycationic molecule 
immobilized on ultrathin pyrolytic graphite electrode surface, after a negatively charged 
gold nanoparticles were immobilized. In the preparation of the negatively charged AuNPs 
modified with AuNPs glutatyondaki glutathione cysteine and glycine with glutamic acid at 
the carboxyl ends of the gold bond to make out the orientation created by the nucleus 
(Zheng and Huang, 2004). Carboxyl ends of the surfaces of nanoparticles created by HRP 
conjugate binding to form an amide bond with the HRP. This structure responds to a 
previous study, an electrochemical 0.28μA/μMlık 0.18μA/μM health changes in more than 
40%. Detection limit of the results showed that more than 3 times. These two tests on 
samples of infected people in the experiments showed a good correlation with ELISA tests. 
This study showed that the province of AuNP with nanomaterials, especially with the 
system established SWCNT due to the sensitivity and accurate results have proven that they 
are suitable for clinical studies. The biggest problem with layers of polymer systems with 
non-specific binding problem should be in front of non-specific binding. 
Wei et al. developed an immunosensor system by electrochemical measurement of the 
amount of PSA performed using Au-Fe3O4 nanoparticle labels. In this study, gold 
nanoparticles on a metal oxide support in support of holding a synergistic effect between 
metal and metal oxide showed higher catalytic activity(Valden et al., 1998, Wang et al., 2009, 
Zheng and Stucky, 2006; Comotti et al., 2006 ; Liu et al., 2006, Lee et al., 2010a). Similarly, 
Wang et al. their study of the structure of Pt-Fe3O4 showed higher catalytic activity than 
single PtNPs determined (Wang et al., 2009b). In this study, dumbbell-like Au-Fe3O4 was 
used to perform catalysis synergistic effect on H2O2. Created a dumbbell-like Au-Fe3O4 on 
the secondary antibody binding to PSA measurement was carried out. Immobilization on 
the surface of the electrode material used a graphene layer in this study. Carbon atoms of 
graphene layers tightly packed, flat two-dimensional honeycomb-like, with a high surface 
area nanomaterials(Geim and Novoselov, 2007, Ohta et al., 2006; Aleiner and Efetov, 2006). 
Because of these features of graphene layers increases the surface area of the installation of 
the primary antibodies, showing a good conductivity of H2O2 helps to determination(Du e 
al., 2010). Graphene layers of graphite oxide was prepared by the method of thermal 
exfolation(McAllister et al., 2007). Graphite oxide, graphene has been modified according to 
the method Hummer(Liu et al., 2008). Au-Fe3O4 dumbbell-like particles, Lee et al. prepared 
and developed method(Lee et al., 2010a) into the secondary antibody solution was added to 
conjugation. Graphene layers are created on the carboxyl groups with amide bonds linked 
with anti-PSA (primary antibody) was created with the GS-conjugate-anti-PSA, BSA was 
used to generated non-specific binding of conjugate to avoid dropping the surface of GCE. 
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On the modified electrode was incubated with PSA at the end on the previously prepared 
were incubated with the addition of Au-Fe3O4-AB2. Peroxide electrode was prepared by 
adding the signal from the Au-Fe3O4 structure as a result of peroxide reduction by the 
amount of PSA was measured. The amount of PSA in the system increases, the increase in 
flow has occurred. Bi-linear system, the measurement of PSA concentration in the range 0.01 
to 10 ng / mL, calculated as the lower limit of determination was found to be 5pg/mL. 
According to Wei et al. there are three factors to determine low amounts that are based on 
the large surface area of graphene layers has increased the installation of the primary 
antibody, Au-Fe3O4 dumbbell-like particles as a result of the high value of the catalytic 
reduction of peroxide increased the conductivity of the layers with the creation of very 
efficient in terms of lower limits were determined. 6.3% RSD value of the system is 
determined, the electrode stability is due to the long-term stability of the NPS Au-Fe3O4. The 
same procedures developed with the ELISA method is less than the deviations between the 
values was observed compared Immunosensors. As a result, the GS large surface area, high 
stability and catalytic activity of Au-Fe3O4 particles of the system has to be sensitive. 
N. Triroj et al. developed miniaturized nanoelectode arrays with microfluidic biochemical 
analysis of the PSA sensor technology. As is well known properties of nano-sized materials 
due to different measurement systems are developed extremely sensitive, fast and easy. For 
instance, the interface in terms of molecular nano-electrodes are stable and electroactive 
molecules are easy to access the center for more sensitive measurements(Shi et al., 2007; Shi 
and Yeh, 2007; Kovochich et al., 2007, Yeh et al., 2007). This is small electrodes on the surface 
of the electrode double layer, increasing the loading materials and diffusion electrochemical 
reactions can be controlled more easily to make the execution. On the other hand, micro-
electrode surface facilitates the mass transport(Norton et al., 1990). High mass transfer is 
important because in this way; biomolecules to the electrode surface of the catalytic reaction 
as a signal to come together and this association creates the first condition can not be 
controlled by diffusion(Armstrong, 2005). The electronic transmission of uniform nano-sized 
electrodes plays a role in increasing signal. Micro-electrode platform, the previous 
configurations(Triroj et al., 2006) unlike in this study as working electrode between the 
electrode arrangement of a micrometer pore  is designed to be5x5 and 5nm. PSA 
determination for the design of microarrays as a sensor electrode surface is primarily the 
formation of the SAM procedure(Achim et al., 2009, Yeh et al., 2010a, b) which was carried 
out with mercaptopropionic acid. Free carboxyl ends of SAM layer activated by NHS / 
EDC, metallized peptide and nucleic acid-incubated with anti-PSA. PNA-ant-regulation of 
PSA(Achim et al., 2009, Yeh et al., 2010a, b) facilitated the immobilization of the electrode 
surface. After the surface of the microarray was incubated with PSA marked with GOx, this 
step was supported by CV datas. Because of the high surface area of microarray, the PSA 
levels in a sensitive way to be determined 4-10ng/mL. Such as the measurement of the 
enzyme suggests the preparation of the electrode marked with the signal extraction based 
on the conversion to glucose. Accordingly, the lower limit is determined as 10pg/mL. 
Qu et al. developed immunosensor based on the marking technique with silica 
nanoparticles for determination of total PSA in human serum. Co-functionalized SiNPs-
antibodies with alkaline phosphatase measurement principle of silver electrodeposition 
measure of the PSA. Silicon nanoparticles have been prepared by the method of emulsion, 
Triton X-100 and hydrophilic silica nanoparticles formed by the addition of hexanol in the 
cyclo hexane (Qu et al., 2008). Solved by adding an appropriate amount of the nanoparticles 
in APTES, glutaric anhydride into the solution containing nanoparticles formed by adding 
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functionalize silicon binding to ALP. Gold electrode was modified with cysteamine solution 
and the amino ends activated with glutaraldehyde that were incubated with the antibody, to 
prevent non-specific binding of aldehyde ends are blocked with BSA. The electrode made of 
silicon nanoparticles drops were modified for sandwich method. On this method, 0.76 ng / 
ml PSA concentrations were determined in lower determination. ALP of the ascorbic acid 2-
phosphate conversion of electrons with the silver particles deposited on the surface of the 
stacked electrode and consequently the signal was measured. For increasing the catalytic 
activity of ALP as a result of the concentration increase has occurred in response to 
electrode. Excess amounts of ALP can help to prevent the sandwich method of attachment. 
Li et al. developed to detection of cancer biomarkers by using nitrodopamin (NDA) with 
functionalized Fe3O4 particles to increase the signal of the electrochemical determination of 
electrochemical immunosensor. The NDA system with a strong anchor agent is a material 
that for immobilization of iron oxide formed by capturing nanoparticles(Young et al., 2009). 
The immobilization material is used to bind both the primary antibodies and secondary 
antibodies. Thionine complex with Fe3O4 and created HRP-AB2 in the presence of peroxide 
is the mediator with Thionine reduce the signal. Fe3O4 nanoparticles synthesized according 
to the method developed by Xu et al.(Xu et al., 2009). NDA was prepared according to the 
study of Malisova et al.(Malisova et al., 2010). NDA-Fe3O4 with the primary antibody was 
immobilized on the modified GCE. This action on the NDA-Fe3O4 modified electrode was 
activated with glutaraldehyde and primary antibody binding blocked with BSA and the free 
ends of the steps to be included. After this containing the solution of PSA in different 
concentrations applied to the surface of the electrode and electrode was incubated for 1 h. 
Finally, the separately prepared solution of NDA-Fe3O4-TH-HRP-Ab2 drops was measured. 
Because of HRP with a weak signal, Fe3O4 particles increased signal and shown better 
conductivity in this system. NDA can increase the loading of antibody and HRP has a 
positive effect on signal. NDA-Fe3O4 formation on the surface of the electrode, CV datas also 
shows that because of attachment the peak would give successfuly. Looking at the 
performance level of immunosensor, 4mM allows the determination of peroxide. This is 
accomplished to the use of TS as the mediator. NDA-Fe3O4 and Fe3O4 was prepared with the 
control experiment, two NDA conjugates shown better measurement limit than 5 times. This 
method is similar to the methods(Qu et al., 2008; Chikkaveeraiah et al., 2009, Yu et al., 2006, 
Liu et al., 2007) compared with measurements carried out have proven much more sensitive. 
The linear detection limit for PSA was in the range of 0,005 to 50 ng / ml. These values fall 
into the range where the normal human values(Lilja et al., 2008). Sensitivity determination 
of immunosensor; IgG, BSA, ǂ-1-fetoprotein (AFP) and glucose 8% of the trials showed less 
interference. Repeatability and reproducibility studies showed for this immunosensor that 
acceptable. 
Yang et al. developed ultrasensitive immunosensor which is modified with a layer of 
graphene. Graphene layers are 2-dimensional structures with high surface area material that 
provides excellent conductivity and stability is described in previous studies. Graphene 
layers for this study is to make the system more sensitive to both the primary antibody 
immobilization and secondary antibodies. Primary antibody immobilization of the 1-
pyrenebutanoic acid adsorbed on graphene layers have been immobilized by using 
sucsinimidyl esters. π-π stacked with the primary antibody attached to the graphene layers 
on the suksinimidyl esters. In graphene layers of graphite oxide was prepared by the 
method of thermal extrafolation(McAllister et al., 2007). Secondary antibody binding stage 
on graphene layers are mixed with thionine by glutaraldeyde to built TH conjugates formed 
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with the active aldehyde residues, on top of them are bond HRP and anti-PSA via aldehyde. 
Primary antibodies were adsorbed on the graphene-1-pyrenebutanoic acid; esters 
sucsinimdyl graphene layers are created with non-specific binding of BSA. This structure is 
attached to the PSA is about to be immobilized on the GCE, and lastly a conjugate addition 
of secondary antibodies were measured by sandwich method. CV scans showed that the 
addition of thionine to facilitate the electron transfer effect. According to Yang et al. there 
are three reasons for this immunosensor for showing high sensitivity, this can be high 
because it is a large amount of surface area of graphene layers with the binding of HRP and 
TH increased signal, HRP showed high catalytic activity and electron transport in graphene 
layers used for the increasing effect of mediator between the TS of the peroxide with HRP. 
Catalytic reaction occurs, the current increases linearly. Linear measurement of PSA 
concentration in the range 0.002 to 10 ng / mL were determined, lower determination limit 
is 1 pg / ml, respectively. The obtained values showed a normal human and cancer patients 
fall into a range of standard values(Lilja et al., 2008). Depending on the sensitivity of the use 
of graphite oxide is used as the GS immunosensor 100 times faster than that observed. 
Children showed a narrower measure by graphite oxide is 0.2 to 2 ng / ml. TH provided the 
reasons for this stability in the long time molecule layer on the graphene π-π jam with 
increased stability of immunosensor, the secondary antibody and HRP on the GS in the 
covalent bonding increases stability. As a result, stability and conductivity of nanomaterials 
used in this study for the immobilization of molecules led to the introduction of ultra-
sensitive immunosensors. 
According to Yang et al. developed another quantum dot functionalized graphene layers as 
a label by the employed for electrochemical immunosensor systems. Graphene layers wide 
surface/volume ratio is preferred because of the reasons stated in previous studies(Liu et 
al., 2010, Wu et al., 2010). Graphene layer immobilization of the study, the primary 
antibodies and secondary antibodies, QD functionalized graphene sheets are used for 
labeling. Designed of immunosensor on graphene layers of graphite oxide were prepared by 
the method of thermal extrafolation(McAllister et al., 2007). GS-QD-AB2 conjugates to be 
done; QD CdCl2 solution preparation stage in the mixed acid solution mercaptoundecanoik 
acid and Cd2+ GS functionalized layer was created. Onto this conjugation Na2S solution 
added when the CdS (QD) funtionalized GS consists of layers. Activated by NHS / EDC 
with secondary antibody that was prepared by adding layers of anti-PSA-QD conjugate to 
GS-formed. GS primary antibody reaction with the surface of the PBSE based amidation 
succinimidyl esters of secondary antibodies were carried out the immobilization via amine 
groups. BSA was used to block non-specific interactions. Secondary antibodies then bond to 
the PSA solution which was prepared after the electrode surface by applying the 
electrochemical measurement were ready. Having a large surface area of the GS with a lot of 
QD increased sensitivity. Electrochemical measurement principle depends on the 
determination of cadmium release from the system. PSA to be determined as a linear 
concentration range 0005 to 10 ng / ml, the lower limit of determination at 3 pg / ml. With low 
limits and Cd2 + ions to determine the QDS functionalized graphene layer is based on the 
determination by showing good conductivity. Graphene oxide layer was prepared with 50 
times more sensitive than other immunosensor system. Repeatability of the electrode as the 
experiments was 7.9% RSD value. Selectivity studies, human IgG, BSA, lysozyme and glucose 
molecules are showing on the initiative of the experiments, the signal has changed by 7%. 
Additionally, the accuracy of this immunosensor showed that good correlation with ELISA 
tests. In table 4, a summary for biosensors developed for detection of PSA is given below. 
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Table Of Electrochemical Transducers For Detection Of PSA 
Measurement 
Technique 
Immobilization 
Technique 
Low 
Detection 
Limit 
Lineer 
Detection 
Limit 
Reference 
Immunochromatog
raphic and 
Electrochemical 
anti-PSA-
QD/nitrocellulose 
membranes 
0.02 
ng/mL 
0.05 to 4 
ng/mL 
Lin et al., 
2011 
Amperometric 
Au-Fe3O4-
AB2/PSA/GC 
5pg/mL 
0.01 to 10 
ng / mL 
Wei et al., 
2010 
Amperometric 
anti-PSA/ 
PNA/GOx/MPA/Micr
oArray 
10pg/mL 
4 to 
10ng/mL 
Triroj et 
al., 2011 
Amperometric 
anti-PSA-
ALP/Cys/AuElectrode 
0.76 
ng/mL 
1 to 
35 ng/mL 
Qu et al., 
2008 
Amperometric 
NDA-Fe3O4-TH-HRP-
Ab2 
0,005ng/m
L 
0,005 to 50 
ng/mL 
Li et al., 
2011 
Amperometric 
Anti-PSA/HRP-
TH/PBA/GC 
1 pg/mL 
0.2 to 2 
ng/mL 
Yang et 
al., 2010 
Conductance GS-QD-anti-PSA 3 pg/ml 
0005 to 10 
ng/mL 
Yang et 
al., 2010 
Table 4. Electochemical Immunosensors developed for Detection of PSA 
3.1.6 Electrochemical immunosensors developed for the determination of VEGF 
Vascular endothelial growth factor has an important role in tumor growth and a biomarker 
metastas. Inordinate amount of time metastasis of VEGF that is structure containing five 
glycoprotein and synthesized large amounts(Augustin et al., 2009). Receptor binding as a 
result of this biomarker of endothelial cells in tissue secreted the excitation function with 
cascade mechanism(Kranz et al., 1999; Kurebayashi et al., 1999; Ruohola et al., 1999, Zhai et 
al., 1999). Rapid proliferation of tumor cells to increased amount of VEGF production. Lung, 
thyroid, breast, gastrointestinal system, kidney and bladder cancer was observed when 
production increases (Ferrara and Davis-Smyth, 1997). 
Prabhulkar et al. developed an amperometric immunosensors system for the determination 
of VEGF. Unfortunately, most of the signal can not be given by non-electroactive biomarker, 
for this reason the use of a marker and a further reaction must be performed by 
measurement. Developed in the measurement of VEGF in this system with ferrocene 
monocarboxylic acid used for labeling, ferrocene monocarboxylic acid was measured by 
using its well known electrochemical properties(Zhang et al., 2008). Ferrocene 
monocarboxylic acid is not given intermediate product of a molecule that can be determined 
by creating fast voltammetric techniques which are very useful. In this study, the carbon 
fiber electrode with high sensitivity, high S / N ratio and increasing the mass transport is 
preferred due to the its good properties. In addition, this type of in-vivo measurements 
paves the way for the use of electrodes. Prepared carbon fiber electrode reported(Ates et al., 
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2008). 4V immersed in the solution containing the carbon fiber electrode potential under 
alylphenol for isolation(Strein and Ewing, 1992). Fc-conjugates of anti-VEGF; first Fc 
dissolved in the buffer, after activated the NHS / EDC and treated anti-VEGF(Lim and 
Matsunaga, 2001). Carbon fiber electrode modification on the mapping carboxylic acid is a 
bifunctional linker was used(Jeffamine). The advantage of using immobilized antibodies 
bind to the effect of Jeffamine was more effective than other linkers(Cao et al., 2007). 
Immobilized antigen-antibody regulation also allows you to fine orientation. Thus, Fc-
derived anti-VEGF was immobilized on the electrode surface. Surface characterization was 
confirmed by SEM scans. Immobilizations are determined by electrochemical CV data. 
Stabilization of covalently immobilized on the surface of the electrode increased. Incubation 
time and amount of anti-VEGF are two major factors in the study. Carbon fiber electrode 
surface, a maximum of 50 to 750 pg / ml antibody binds to the Fc-immobilized with anti-
VEGF; this value rises to 800pg/mL. Lower limit of determination of VEGF 38 pg / ml, 
respectively. The maximum value of RSD 8.9%. Specificity studies of this immunosensor 
was carried out with IgG and did not give an important signal. 
Kim et al. developed for the determination of VEGF in another study,  indium tin oxide 
layer on the metal nanoparticles electrochemical measurement system. Recently metal 
nanoparticles on biosensor technology with immobilized electrodes are used widely. In this 
study, AuNPs / ITO electrode modified with the VEGF level was measured. AuNPs 
primarily prepared in accordance with the protocol developed by Kumar et al.(Kumar et al., 
2008). Then attached to the surface of the electrode modified with AuNPs by APTES(Seiwert 
et al., 2008). ITO electrode modified with AuNPs of VEGF after treatment were immersed in 
a solution of BSA to prevent non-specific binding. VEGF gold nanoparticles were covalently 
modified with thiol groups to connect to the 2-MEA was obtained to be rendered. This is 
anchored on thiol groups of VEGF with sorrowful AuNPs VEGFantibodyfragment / AuNPs 
/ APTES / ITO modified electrode formed. Fc-fragments of anti-VEGF prepared after 
modification is as follows: Fc condition with anti-VEGF conjugate formed through the 
activation of the anhydride(Kossek et al., 1996). This conjugate was prepared by applying 
the modified electrode surface was measured. One of the important points of the steps of 
immobilization induced by 2-MEA that is the process of purification of fragments. 
Electrochemical analysis of measurement systems used in the CV and DPV. Lower 
determination limit was determined as 100pg/mL. Table 5 shows voltammetric based 
immunosensors for PSA. 
 
Table Of Electrochemical Transducers For Detection Of PSA 
Measurement 
Technique 
Immobilization Technique 
Low 
Detection 
Limit 
Lineer 
Detection 
Limit 
Reference 
Voltammetric 
Fc-derived-anti-VEGF 
/Jeffamine/CFE 
38 pg/mL
50 to 750 
pg/mL 
Prabhulkar 
et al., 2009 
Voltammetric 
AuNPs/VEGFantibodyfragment/ 
AuNPs /APTES/ITO modified 
electrode 
100 
pg/mL 
100 to 
600 pg/mL
Kim et al., 
2009 
Table 5. Voltammetric Immunosensors For Detection of PSA 
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3.2 Optic transducers 
Especially in the field of optical transducers; fluorescence, inferometry, optical wave 
spectroscopy, and surface plasmon rezonance used in sensor systems(Tothill, 2009). Usually 
the light emissions of fluorescence signal to realize biocomponents, QD etc. are used to 
create the signaling molecules. Especially in recent days at the molecular level without need 
to label the SPR technology allows the immunochemical analysis. Determination was carried 
out in very specific, allowing real-time analysis(Keusgen, 2002, Yang et al., 2005; 
Vaisocherova et al., 2007). Nanocrystals are used for labeling luminescent molecules for 
molecular and cellular imaging(Maxwell et al., 2002; Gerion et al., 2001; Gerion et al., 2002, 
Kim et al., 2004). 
3.2.1 Development of the optical Immunosensors for the determination of AFP 
Bi et al. developed for the determination of biomarker AFP multilayer enzyme-coated 
ultrasensitive chemiluminescent immunoassay system. In this system, the carbon 
nanaotubes are used for immobilization material. Besides the high stability and 
luminescence properties of the surface area of carbon nanotubes in the winning offers 
impressive features(Sumpter et al., 2008, Shen et al., 2004; Tasis et al., 2006). The study 
functionalize carbon nanotubes with carboxyl groups can be treated primarily by acid, and 
they were now ready for immobilization(Mung et al., 2005). On the carboxyl groups formed 
on the MWCNT then coated with PDDA. The positively charged PDDA was immobilized 
on the negatively charged HRP (HRP / PDDA) n / MWCNT multilayer structure of the 
enzyme were continued several times in this study by creating layered system formed. HRP 
immobilized on the PDDA-MWCNT after the negatively charged PSS adsrobe on this 
structure on the  then secondary AFP antibodies were added and MWCNT-(PDDA / HRP)4-
PDDA/PSS-Ab2 modification prepared. MBs with the primary antibody conjugated with the 
method have been developed by the Imato and colleagues (Zhang et al., 2007a, b). LBL films 
as a result of sandwich type immuno complex, depending on the enzyme activity by 
measuring the permeability values of the system. In this system, the amount of 1ng/mL was 
determined at the level of AFP. AFP linear measurement is between 0.02 to 2 ng / ml. A 
successful realization of the system as a result of the signal by increasing the light 
interaction with the CNT-LBL bio pointer by measuring the high sensitivity, good accuracy 
and operational stability as a result offers the possibility to analyze very large amounts. 
3.2.2 Immunosensors based SPR for detection of CRP  
CRP, a biomarker, is very well known. As mentioned in previous sections of early diagnosis 
is extremely important. Meyer et al. developed to allow different samples to be analyzed in 
combination with SPR sensor technology. SPR is an optical instrument and proteins, binding 
of antigen and antibodies used in monitoring processes. The biggest advantage of up to 
eight analyte by a measurement provides for a shorter time(Meyer et al., 2006). In this study, 
the biotin-coated gold electrodes used with a layer of APTES(Davidson et al., 2004; Phadtare 
et al, 2004; Yakovleva et al., 2003), thus creating an amino surface with biotin-NHS match 
ends formed. On this layer and biotinylated streptavidin antibody(Milka et al., 2000) on the 
application of CRP measurement was carried out by applying the secondary antibody. Kdis, 
antigen-antibody method, the values can be determined easily. For this purpose, Edwards 
and Leatherbarrow method(1997) was used. BSA is used to prevent non-specific binding of 
the system. Whether the application shows a significant increase in signal for 1μg/mL 
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example. In this case, the signal has been more than 4 times the noise and the lower limit of 
determination. Dynamic and linear measuring range 2 mg / ml to 5 mg / mL were 
determined. SPR sensor was developed in two different CRP antibody (C2 and C6) have the 
possibility of measurement separately. SPR sensor, two different epitope of these two 
biomolecule identification of features of the high specificity can be determined. Designed 
using the most important feature of the SPR biosensor is that has no limitations, such as 
ELISA, sample color, origin, or allow the possibility of measurement can yield without 
affecting the matrix. 
3.2.3 SPR based biosensors developed for determination of CEA 
Ladd et al. developed SPR-based measurement system for direct determination of CEA. As 
is known in real-time SPR, and do not need to label the quantitative determination of 
biomolecules is a measurement technique that allows each opportunity. Cancer diagnosis is 
very important in the early diagnosis offers the possibility to analyze. In this study the clone 
ovarian cancer in terms of levels of anti-CEA levels were used to determine by SPR sensor. 
In order to verify the measurement system, the data obtained from samples were confirmed 
by ELISA. The sensor is based on the measurement of total reflectance method(Boozer et al., 
2004, Ladd et al., 2004). Polychromatic light source, optical prism reflecting light rays 
emitted from a thin metal layer after the reflected rays fall on the four independently 
collected by the spectrophotometer so that allows you to create 4 different measurement 
channels. In this study, 2nm thick Cr and 55nm thick gold electrode surface is covered 
electron beam evaporation. After cleaning the electrode surface with UV COOH-
oligoetilenglikol: PGP solution is created with the SAM. Functionalized with COOH groups 
on the SAM layer, activated NHS / EDC and proteins were immobilized. After this process 
was the determination of CEA antibody in serum samples were applied to the electrode 
surface by the flow system. In the second sample solution containing the secondary 
antibodies anti-human IgG-HRP conjugate was applied. Compared with the ELISA method 
for direct analysis of the SPR signal of study of molecules has a higher response. ELISA and 
SPR studies that there are two different cases of non-specific binding Ladd et al. 
determinism which causes the application of surface chemistry and the sample. Surface 
modification and protein immobilization of the SPR and ELISA is shown by the many 
differences. SPR analysis of CEA as a result the basic purpose of this study consisted of 
developing immunosensor and ELISA tests for confirmation of the results of CEA was 
measured directly. 
3.2.4 SPR based biosensors developed for determination of HER-2  
Gohring et al. developed very different system for the determination of HER-2 for the 
diagnosis of breast cancer, opto-fluidic biosensor system using the ring resonator. As is 
known, the most common cancer among women is breast cancer, only 200,000 women in the 
USA affected by breast cancer(Cheng et al., 2009; Lippman, 2008; Jemal et al., 2006). The 
early diagnosis of cancer in recent years to study protein basis biomarkers the most widely 
used on the issue(Kearney and Murray, 2008; Gullick, 2001). Excessive secretion of growth 
factor receptor in human epidermis occurs during breast cancer. HER-2 levels in healthy 
people are between 2 to 15 ng/mL, sick people are between the 15 to 75ng/mL(Capobianco 
et al, 2008). For this reason, the quantitative detection of biomarkers need to be fast and 
responsive. Ring resonator was used for analysis in this study, thin high-Q ring resonator on 
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microfluidic system used to support the capillary walls. In this experiment by heating the 
desired radius under OFRRs silica glass door until it pulled carbon dioxide laser has been 
extended to increase the sensitivity of HF were treated with less than 3μm around to 5μm 
thickness were produced(White and Oveys, 2006, Zhu et al., 2008, White et al ., 2008). 
Interact with light in a fiber ring connecting the cable OFRR resonance, known as 
whispering gallery mode(WGM) creates. 1550nm laser diode used in this experiment can be 
adjusted in length (Fig. 3). 
 
 
Fig. 3. A schematic representation of AFP sensing by a microfluidic immunosensor system 
Nanometer size of measurement unit as a measure of sensitivity to OFRR each diffraction 
measurement of the index unit (RUI). OFRR inner surface (Fig. 3) the preparation should be 
modified to show the great sensitivity with small concentrations. First of all HF from the 
surface through the surface will be loaded. Then, the surface layer of 3-APS is obtained by 
passing an aminosilan. After passing through the DMP, then the creation of a layer of cross-
linking of recombinant protein G immobilized on aminosilan surface, immobilization of this 
protein, the G antibodies provided orientation. In order to prevent non-specific binding, 
casein was used in blocking agent. HER2 biomarker 13, 16, 20, 25, 33, 50, 75, 100 and 250 ng 
/ ml, all experiments were completed in 30 minutes, the ring was cleaned after each use 
with the HF. Casein-bound or loosely linked with HER2 after treatment with antibodies 
were to remove the casein solution from the system. This is a specially designed syringe 
pump is used for transactions. Lower determination of limit is 10ng/mL. 0.3pm is observed 
as a negative shift of the shift measurements, the sample is applied, showed that 4.5 pm 
shift. The only disadvantage of the system haven’t been found better biomolecule to prevent 
non-specific binding of system. Conclusion Gohring et al. by responding to the rapid, 
sensitive and reproducible system was developed quickly. 
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3.3 Piezoelectric transducers 
Hereinafter piezoelectric quartz crystals to provide mass to hear the transducers unlabeled 
measurements and the electrode on the surface of the gold-coated sensors are designed 
using the small mass changes depending on the measurement of change are based on the 
crystal resonance differences(Sullivan and Guilbault, 1999). Label was using a variety of 
recently developed systems for QCM immunosensors(Kurosawa et al., 2004, McBride and 
Cooper, 2008). QCM sensors, the biggest disadvantage of solution matrix applied to any 
kind of analyte. 
3.3.1 QCM based biosensors developed for determination of CRP 
Kim et al. QCM-based indirect competitive immunosensor systems developed for the 
determination of CRP. In this system, an indirect competitive QCM immunosensor system 
(IC) as the startup process as a monoclonal anti-CRP antibody was immobilized and was 
measured in serum biomarkers. Transducer in the system for measuring the surface has 
been prepared according to the method developed by Park and Kim (Park and Kim, 1998). 
QCM surface was treated separately, first sodym hydroxide and hydrochloric acid. The 
sensor surface is covered with sulfo-LC-SPDP is prepared for immobilization of antigen to 
be taken as a result of previous studies that suggested the best sensitivity (Park and Kim, 
1998). Mixed with sulfo-LC-SPDP dithioeritrol CRA and CRP reacted with the latest sensor 
QCM gold electrode surface was prepared by treatment. High ionic strength was chosen to 
minimize the false positive signal and time of CRP measurement(Kim et al., 2004). In this 
study, a relatively high concentration of immobilized antigen-antibody binding and 
measurement is good. After that, the sensor response to an antigen-antibody interaction is 
between 0010 to 0.5 mg / mL antibody concentration was determined. Specificity studies 
with BSA bind to the surface of the sensor, almost no binding was observed with BSA. 0,130 
to 25,016, depending on the time sensitivity of the sensor were examined ng / mL, in a 
linear range to be determined. IC, according to the response of the sensor decreases with 
increasing concentration of CRP (Hamalek et al., 2002; Adanyi et al., 2007). Prepared by the 
same enzyme system in the 0.3 ng / mL lower limit determined in this study, moreover, a 
close 87fM validation coefficient was calculated as 0.9893. 
Kim et al. Immunosensors QCM gold nanoparticle-based systems have developed that 
increase the signal. In this study with the help of AuNPs the signal was amplified 
significantly. Streptavidin-coated gold nanoparticlws complexation of antigen antibody was 
measured by the IC assay format. Anti-CRP buffer by dissolving into the sulpho-NHS-LC-
biotin was carried out by adding antibodies. QCM surface, hydro-chloric acid and sodium 
hydroxide in a separate location after being treated with sulpho-LC-SPDP to conjugate CEA 
was created by mixing the solution after the mixture was incubated with dithioeritrol tihol 
groups that hosts on the conjugated CRP, QCM was immobilized on the drops. Established 
a system of micro-flow system with the help of dispersing peristalsis sample pump is smart. 
At this point the resonance frequency was obtained from stationary phase. After a series of 
solution containing biotinylated that anti-CRP applied to 0.1pM between 0.53nM. According 
to the obtained resonance shift and bonded CRP measurement was carried out by the 
changes resulting from the resonance shift observed. In this study, performance of 
immunosensor is increased with the implementation of the nanomaterials. As for the 
sensitivity of the system on chip, 2 mg / mL antigen coated, biotinilated and competitive 
reaction between the free CRP, decreased concentration brings increased differentiation 
frequency (Halamek et al., 2002). Accordingly, the relative rate of antibody binding 
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decreases. These values indicate that antibodies bound on AuNPs attached with a mass 
deposition. According to the data being compared with the control value obtained by 
adding the shift 1pm shift control measurement of CRP is less than that observed. Based on 
this data to determine the lower limit is determined as 0.1pM. AuNPs on the surface have 
increased the sensitivity of the sensor. This method is more sensitive compared with other 
measurement methods based on related data have shown that (Meyer et al., 2002, Meyer et 
al., 2007; Vikholm-Lundin et al., 2006). 87fM be determined until this study, low-range 
signal. Verification of the system is determined as coefficient of 0.9796. Thus, the use of 
modified antibodies with increased sensitivity of the IC immunosensor QCM decreased to 
low levels of CRP measurement limits. Table 6 summarizes immunosensors based QCM for 
CRP detection. 
 
Table Of QCM Transducers For Detection Of CRP 
Measurement 
Technique 
Immobilization Technique 
Low 
Detection 
Limit 
Lineer 
Detection 
Limit 
Reference 
QCM 
CRP/DTHE/sulfo-LC-
SPDP/QCM 
0.3 ng / mL 
(87fM) 
0010 to 0.5 
mg/mL 
Kim et al., 
2010 
QCM 
Anti-CRP/sulpho-NHS-LC-
biotin/QCM 
2 mg / mL 
(0.1pM) 
0.1pM to 
0.53nM 
Kim et al., 
2009 
Table 6. QCM Immunosensor For Detection Limits Of CRP 
3.3.2 QCM based biosensors developed for determination of PSA 
Another study using the QCM Immunosensors Uludağ and Tothill developed an 
immunosensor based on the measurement of the amount of PSA using nanoparticles in 
human serum (75%). As is well known that is important early diagnosis of cancer which 
death rate among men with prostate cancer is known to be high, and confirmed by the 
WHO datas(Panini et al., 2008). In this study, a simple and rapid determination of the PSA is 
designed to carry out the QCM biosensor. As is well known among the QCM contains two 
electrode in a couple of thin layers of quartz (wafer). Mass loss or a mass connected to the 
surface by measuring the change in frequency allows the analysis. Although the analyte 
solution, the viscosity of the system are affected in the determination of the serum samples 
were carried out on the biomarker in this study. To minimize the matrix effect; the 
detergent, salt and other substances were used to measure the PSA and PSA-ACT complex. 
First, gold nanoparticles formed, were treated with anti-PSA conjugate. After the QCM gold 
disc for the purpose of the creation of a MUA SAM layer is covered with all night long. 
After NHS / EDC activation with anti-PSA and on the SAM-coated chip for controlling the 
flow rate used in the IgG molecule 80μl/min to be applied. Connecting to BSA and 
ethanolamine were used to block the non-active carboxyl groups. Frequency measurement 
was carried out in two minutes after the injection of proteins. PSA complex in serum is in 
conjunction with the ACT. This is a combination of two molecules by the presence of total 
PSA (tPSA) can be quantified. In this study, accurate measurement of this complex due to 
the mixing ratio of 1:1 was used PSA and PSA-ACT complex. After this process of IgG 
binding to the anti-PSA and then to 380 and 520 Hz frequency change of the order have 
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been observed. BSA surface with no frequency change is observed during the application of 
surface blocked were good in terms of measurement. PSA is given to the method of 
Sandwich, first applied to the surface of the electrode only sample of anti-PSA in 5Hz 
frequency change was recorded accordingly. Linear measurement range of the experiments 
with PSA 2.3 to 150 ng / mL was determined. With this method, sandwich method to 
determine, direct determination limit is more sensitive 4 times. As is well known for quartz 
disk viscosity is affected when applied to the buffer and serum samples showed different 
results. Sample is applied to determine the lower limit of 10% serum containing 10.2 ng / ml 
to 18.1 ng /ml. Non-specific binding of carboxymethyl dextran is used to prevent non-
specific binding of the surface decreased by 88% (Choi et al., 2006, Yin et al., 2005). In this 
study, experiments in human serum with 75% diluation as a result of the realization of the 
measurement process as a linear 150ng/mL hesaplanmıi 100% to determine the serum ratio 
of 0:29 was determined as the 0.39ng/mL. In this study, the rate of change in the 
measurement of serum with additives will be examined and analyzed by 98% of non-
specific binding of different additives were crossed in front. 
4. Conclusion 
It is vitally important to diagnose cancer early for treatment patients succesfully. 
Consequently there will always be a need to develop more sensitive, economical, and simple 
diagnostic biosensors because new cancer biomarkers are discovered continuously. 
Biosensors have the potentiality to diagnose cancer sensitively, simply, and economically. 
Unfortunatelly the biosensor based measurement systems need to be further developed to 
use these devices in analyzing of many cancer biomarkers simultaneously. Consequently, as 
a future prospestive, biosensor technology should gear to adapt these systems for multi 
target analysis by the help of microfluidics technologies. Beside using of the newly 
discovered nanomaterials in the development of biosensors can increase the sensitivity and 
selectivity of these devices.  
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